C

Cancervax (merged to Micromet)

12 employees

Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pharmaceutical

Date founded

2021

Funding rounds raised

Total raised

$55M

from 13 investors over 13 rounds

C

Cancervax (merged to Micromet) raised $40M on October 3, 2008

Investors: Merlin Nexus, Index Ventures, Abingworth and DAFNA Capital Management, LLC

C

Cancervax (merged to Micromet) raised $41M on August 13, 2003

Investors: Vector Fund Management and Forward Ventures

C

Cancervax (merged to Micromet) raised undisclosed on August 31, 2002

Investors: SV Life Sciences

C

Cancervax (merged to Micromet) raised $55M on April 5, 2002

Investors: Vector Fund Management and Forward Ventures

C

Cancervax (merged to Micromet) raised undisclosed on February 25, 2002

Investors: Vector Fund Management

C

Cancervax (merged to Micromet) raised $11M on April 17, 2000

Investors: Abingworth, 3i Group plc and Atlas Venture

FAQ